Nautilus Biotechnology GAAP EPS of -$0.11 beats by $0.03
Source: SeekingAlpha
2026-02-26 08:38:48 ET
More on Nautilus Biotechnology
- Seeking Alpha’s Quant Rating on Nautilus Biotechnology
- Historical earnings data for Nautilus Biotechnology
- Financial information for Nautilus Biotechnology
Read the full article on Seeking Alpha
For further details see:
Nautilus Biotechnology GAAP EPS of -$0.11 beats by $0.03
Nautilus Biotechnology Inc.
NASDAQ: NAUT
NAUT Trading
1.82% G/L:
$2.515 Last:
106,125 Volume:
$2.45 Open:
NAUT Latest News
March 02, 2026 08:00:00 am
Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales
February 26, 2026 08:00:00 am
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial Results
February 24, 2026 08:00:00 am
Nautilus Biotechnology Unveils Voyager Platform, Enabling Single-Molecule Iterative Mapping, at US HUPO 2026
NAUT Stock Data
$266,503,807
49,511,608
N/A
20
N/A
Biotechnology & Life Sciences
Healthcare
US
Seattle
